Mechanism of Zizao Yangrong Formula in treating skin xerosis caused by anti-cancer targeted drugs

PENG Yanmei; WANG Fuqing; ZHANG Xu; LI Jia; TAN Kexin; GAO Yajun; SHI Yanan; CUI Huijuan

doi:10.16025/j.1674-1307.2024.06.014

您当前的位置：

首页 >

文章列表页 >

Mechanism of Zizao Yangrong Formula in treating skin xerosis caused by anti-cancer targeted drugs

更新时间：2024-07-29

- Mechanism of Zizao Yangrong Formula in treating skin xerosis caused by anti-cancer targeted drugs
- Beijing Journal of Traditional Chinese Medicine Vol. 43, Issue 6, Pages: 645-654(2024)
- 作者机构：
  
  1.北京中医药大学房山医院肿瘤科，北京 102400
  2.北京中医药大学研究生院，北京 100029
  3.中日友好医院中西医结合肿瘤科，北京 100029
- 作者简介：
- 基金信息：
- DOI：10.16025/j.1674-1307.2024.06.014
  CLC：
- Published：25 June 2024，
  
  Received：09 August 2023，
- 稿件说明：
扫描看全文
彭艳梅，王福庆，张旭，等.滋燥养荣方治疗抗肿瘤靶向药所致大鼠皮肤干燥的分子机制［J］.北京中医药，2024，43（6）：645-654.

PENG Yanmei,WANG Fuqing,ZHANG Xu,et al.Mechanism of Zizao Yangrong Formula in treating skin xerosis caused by anti-cancer targeted drugs[J]. Beijing Journal of Traditional Chinese Medicine,2024,43(06):645-654.
彭艳梅，王福庆，张旭，等.滋燥养荣方治疗抗肿瘤靶向药所致大鼠皮肤干燥的分子机制［J］.北京中医药，2024，43（6）：645-654. DOI： 10.16025/j.1674-1307.2024.06.014.

PENG Yanmei,WANG Fuqing,ZHANG Xu,et al.Mechanism of Zizao Yangrong Formula in treating skin xerosis caused by anti-cancer targeted drugs[J]. Beijing Journal of Traditional Chinese Medicine,2024,43(06):645-654. DOI： 10.16025/j.1674-1307.2024.06.014.

摘要

目的

基于网络药理学分析和动物实验探讨中药滋燥养荣方治疗抗肿瘤靶向药所致皮肤干燥的分子机制。

方法

采用在线数据库筛选滋燥养荣方各单味药成分的靶点和皮肤干燥及瘙痒的靶点，对共同靶点进行分析，通过通路富集预测中药可能的效应途径。应用靶向药吉非替尼建立与患者皮肤干燥皮损表现一致的大鼠模型，分为模型组、阳性对照组和中药组，分别予生理盐水、维生素E乳、中药进行干预，以正常大鼠作为正常对照组，观察各组皮肤表型、组织病理学变化、信号通路相关蛋白和炎症因子表达。

结果

滋燥养荣方各单味药筛选出预测靶点共3 125个，靶向药所致皮肤干燥及伴有瘙痒的对应靶点共660个。对173个共同靶点进行分析，通路富集预测结果显示表皮角质细胞内磷脂酰肌醇-3-激酶（PI3K）-丝苏氨酸蛋白激酶B（Akt）通路可能是中药起效的信号途径。动物实验表明，与正常对照组比较，其余各组均出现靶向药相关的皮损、结痂、脱屑等皮肤干燥表现；与模型组比较，阳性对照组和中药组小鼠的皮肤干燥均改善，中药组小鼠皮损愈合、毛发生长情况优于阳性对照组。与正常对照组比较，模型组表皮增厚（

0.05）；与模型组比较，阳性对照组、中药组表皮厚度变薄（

0.05）。与正常对照组比较，模型组Akt蛋白和p-Akt 308蛋白染色呈棕黄色，强度较弱；与模型组比较，中药组Akt蛋白和p-Akt 308蛋白染色呈棕黄色，强度较强，且强于阳性对照组，与正常对照组相近。各组p-Akt 473蛋白染色强度差异不明显。Western blotting检测结果：与正常对照组比较，中药组皮肤组织中p-Akt 308蛋白相对表达量低（

0.05）；与模型组比较，中药组皮肤组织中p-Akt 308蛋白相对表达量高（

0.05）。各组皮肤组织及血清炎症因子水平比较差异无统计学意义（

0.05）。

结论

中药滋燥养荣方能缓解抗肿瘤靶向药所致大鼠局部皮肤炎症、促进皮肤修复，其分子机制可能与Akt相关信号通路有关。

Abstract

Objective

To explore the molecular mechanism of Zizao Yangrong Decoction （ZYD） in treating skin xerosis caused by anti-cancer targeted drugs based on network pharmacological analysis and animal experiments.

Methods

Online databases were used to search for the corresponding targets of each single herb included in ZYD and skin xerosis and pruritus. The shared targets were analyzed and used to predict the possible effect pathways through pathway enrichment. Rat model consistent with patients' dry skin lesions by targeting drug gefitinib was established， and were divided into model group， positive control group and Chinese herb group， which were treated by normal saline， vitamin E cream， ZYD respectively. Compared with normal rat， the skin phenotype， histopathological changes， the expression of signal pathway-related proteins and inflammation factors were observed.

Results

Single herb of ZYD was screened out a total of 3125 predicted targets. Targeted drugs-induced skin xerosis which was accompanied by pruritus and caused by targeted drugs was screened out a total of 660 targets. 173 targets shared by ZYD and diseases were analyzed. Pathway enrichment showed that PI3K-Akt pathway might be the signal pathway of the effect of ZYD. Animal experiments showed that compared with normal group， rats in other groups developed target drug-related skin xerosis like lesion， scrab and desquamation. Compared with model group， the dryness of skin condition of rats in positive control group and experimental group were improved. The improvement of skin healing and hair growth in experimental group were better than that in positive control group. In the model group， Akt protein and p-Akt 308 protein were stained brown and the intensity was weak. Compared with the model group， Akt protein and p-Akt 308 protein in the Chinese herb group were brown， and the intensity was stronger than that in the positive control group， which was similar to that in the normal control group. There was no significant difference in the staining intensity of p-Akt 473 protein among the groups. Western blotting results： compared with the normal control group， the relative expression of p-Akt 308 protein in the skin tissue of Chinese medicine group was lower（

0.05）； compared with the model group， the relative expression of p-Akt 308 protein in the skin tissue of Chinese herb group was higher（

0.05）. There was no significant difference in the levels of inflammatory factors in

skin tissue and serum among the groups（

0.05）.

Conclusion

Chinese herb ZYD might have a therapeutic effect on targeted drugs-associated skin xerosis by relieving inflammatory reaction and promoting skin recovery， in which Akt-related pathway might be involved.

关键词

滋燥养荣方靶向药皮肤干燥网络药理学大鼠分子机制

Keywords

Zizao Yangrong Formulatargeted drugsskin xerosisnetwork pharmacologyratmolecular mechanisms

references

GISONDI P, GEAT D, MATTIUCCI A, et al. Incidence of adverse cutaneous reactions to epidermal growth factor receptor inhibitors in patients with non-small-cell lung cancer[J]. Dermatology, 2021,237(6):929-933.

TSENG LC, CHEN KH, WANG CL, et al. Effects of tyrosine kinase inhibitor therapy on skin toxicity and skin-related quality of life in patients with lung cancer: An observational study[J]. Medicine (Baltimore), 2020,99(23):e20510.

PASTORE S, LULLI D, GIROLOMONI G. Epidermal growth factor receptor signalling in keratinocyte biology: implications for skin toxicity of tyrosine kinase inhibitors[J]. Arch Toxicol, 2014,88(6):1189-1203.

BARTON-BURKE M, CICCOLINI K, MEKAS M, et al. Dermatologic reactions to targeted therapy: a focus on epidermal growth factor receptor inhibitors and nursing care[J]. Nurs Clin North Am, 2017,52(1):83-113.

JOLY-TONETTI N, ONDET T, MONSHOUWER M, et al. EGFR inhibitors switch keratinocytes from a proliferative to a differentiative phenotype affecting epidermal development and barrier function[J]. BMC Cancer, 2021,21(1):5.

PENG YM, DUAN H, ZHANG JY, et al. Application of Zizao Yangrong Granules for treating targeted drugs–related skin xerosis: A randomized double-blinded controlled study[J]. Integr Cancer Ther, 2020,19:1-9.

RU J, LI P, WANG J, et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines[J]. J Cheminform, 2014,6:13.

ZHOU W， WANG Y， LU A， et al. Systems pharmacology in small molecular drug discovery[J]. Int J Mol Sci， 2016，17（2）：246.

GAO L, WANG XD, NIU YY, et al. Molecular targets of chinese herbs: a clinical study of hepatoma based on network pharmacology[J]. Sci Rep, 2016,6:24944.

LI YH， YU CY， LI XX， et al. Therapeutic target database update 2018： enriched resource for facilitating bench-to-clinic research of targeted therapeutics[J]. Nucleic Acids Res， 2018，46（D1）：D1121-D1127.

WISHART DS, FEUNANG YD, GUO AC, et al. DrugBank 5.0: a major update to the DrugBank database for 2018[J]. Nucleic Acids Res, 2018,46(D1):D1074-D1082.

PIñERO J, BRAVO À, QUERALT-ROSINACH N, et al. DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants[J]. Nucleic Acids Res, 2017,45(D1):D833-D839.

AMBERGER JS, HAMOSH A. Searching online mendelian inheritance in man (OMIM): A knowledgebase of human genes and genetic phenotypes[J]. Curr Protoc Bioinformatics, 2017,58:1.2.1-1.2.12.

STELZER G, ROSEN N, PLASCHKES I, et al. The genecards suite: from gene data mining to disease genome sequence analyses[J]. Curr Protoc Bioinformatics, 2016,54:1.30.1-1.30.33.

SZKLARCZYK D, FRANCESCHINI A, KUHN M, et al. The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored[J]. Nucleic Acids Res, 2011,39(Database issue):D561-568.

SHANNON P, MARKIEL A, OZIER O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks[J]. Genome Res, 2003,13(11):2498-2504.

BADER GD, HOGUE CW. An automated method for finding molecular complexes in large protein interaction networks[J]. BMC Bioinformatics, 2003,4:2.

HUANG DW, SHERMAN BT, LEMPICKI RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources[J]. Nat Protoc, 2009,4(1):44.

张心悦,彭艳梅,徐央波,等.肺腺癌患者应用表皮生长因子受体抑制剂治疗后皮肤不良反应的中医症候特点[J].中医杂志,2015,56(16):1401-1405.

刘海龙,吴国泰,王瑞琼,等.当归黄芪醇提取物对实验性皮肤瘙痒模型的药效学研究[J].中国实验方剂学杂志,2012,18(1):200-202.

崔瑛,房晓娜,王会霞,等.地黄不同炮制品补血作用研究[J].时珍国医国药,2009,20(1):20-23．

祝双来,黄洪林.黄芩黄酮类化合物抗炎作用机制研究进展[J].江西中医学院学报,2010,22(3):97-100.

聂安政,林志健,王雨,等.秦艽化学成分及药理作用研究进展[J].中草药,2017,48(3):597-608.

辛国,李鑫,黄晓巍.防风化学成分及药理作用[J].吉林中医药,2018,38(11):1323-1325.

WAN L, WANG Y, TANG Y, et al. Gefitinib-induced cutaneous toxicities in brown norway rats are associated with macrophage infiltration[J]. Inflammation, 2020,43(6):2137-2146.

SANO K, NAKADATE K, HANADA K. Minocycline prevents and repairs the skin disorder associated with afatinib, one of the epidermal growth factor receptor-tyrosine kinase inhibitors for non-small cell lung cancer[J]. BMC Cancer, 2020,20(1):279.

SEO SH, JEONG GS. Fisetin inhibits TNF-α-induced inflammatory action and hydrogen peroxide-induced oxidative damage in human keratinocyte HaCaT cells through PI3K/AKT/Nrf-2-mediated heme oxygenase-1 expression[J]. Int Immunopharmacol, 2015,29(2):246-253.

TAN AR, STEINBERG SM, Parr AL, et al. Markers in the epidermal growth factor receptor pathway and skin toxicity during erlotinib treatment[J]. Ann Oncol, 2008,19(1):185-190.

KIM JM, JI JH, KIM YS, et al. rhEGF treatment improves EGFR inhibitor-induced skin barrier and immune defects[J]. Cancers (Basel), 2020,12(11):3120.

GERBER PA, BUHREN BA, SCHRUMPF H, et al. Mechanisms of skin aging induced by EGFR inhibitors[J]. Support Care Cancer, 2016,24(10):4241-4248.

ZOUBOULIS CC. Epidermal growth factor receptor and the sebaceous gland[J]. Exp Dermatol, 2013,22:695-696.

DAHLHOFF M, DE ANGELIS MH, WOLF E, et al. Ligand-independent epidermal growth factor receptor hyperactivation increases sebaceous gland size and sebum secretion in mice[J]. Exp Dermatol, 2013,22(10):667-669.

IKARASHI N, KANEKO M, WATANABE T, et al. Epidermal Growth factor receptor tyrosine kinase inhibitor erlotinib induces dry skin via decreased in Aquaporin-3 Expression[J]. Biomolecules, 2020,10(4):545.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Mechanism of Jianpi Shugan Guben Formula for diarrhea-predominant irritable bowel syndrome based on network pharmacology and animal experiment

Observation on the mechanism of Sanshen Tongmai Mixture on chronic heart failure rats

Study on the regulatory effect of Yuxian Formula on retention enema on PXR/NF-κB signaling pathway and inflammatory factors in rats with ulcerative colitis of damp-heat type in large intestine

Exploring the potential mechanism of Jianpi Qinghua Huayu Decoction in the treatment of precancerous lesions of gastric cancer based on network pharmacology combined with GEO chip analysis and molecular docking technology

Mechanism of Astragaloside IV on diabetic nephropathy induced by Streptozotocin in rats

Related Author

LIU Nian

LI Jielei

LI Danyan

ZHANG Shengsheng

TENG Fei

WANG Zhen-yu

LI Ran

YANG Zhen-bin

Related Institution

Beijing Hospital of Traditional Chinese Medicine Affiliated to the Capital Medical University

Beijing University of Chinese Medicine

Department of Health Care for Cadres， Beijing Hospital of Traditional Chinese Medicine Affiliated to the Capital Medical University

Spleen and Stomach Diseases Department， Yangzhou Hospital Affiliated to Nanjing University of Traditional Chinese Medicine

School of Clinical Medicine， Beijing University of Chinese Medicine

⁰